Skip to content

WellCareChina

Independent medical information for international patients

Menu

Disease

Assisted reproduction (IVF)辅助生殖（IVF）

ICD-10: Z31 — In vitro fertilisation

National medical service item code: Oocyte retrieval 取卵术; Embryo transfer 胚胎移植; (the 12 items consolidated by the price-item guidelines) （立项指南整合 12 项）

Group: Non-tumor Specialty: Reproductive Medicine

Key figures

Published values only. Every tile opens the section that carries its source, its year and its caliber.

Disease details

Standard Chinese name
辅助生殖（IVF）
English name
In vitro fertilisation

Values written in Chinese are quoted as published by the source.

Also known as

  • Assisted reproduction (IVF)
  • In vitro fertilisation
  • In vitro fertilization
  • IVF

Treatment cost ranges

Every range below is published on one billing basis: Pre-reimbursement 医保报销前. The sources publish no post-reimbursement figure, so none is shown here.

Treatment path Cost range Price basis Data year
Surgery 手术 1000 – 1000 CNY Per-item price 项目价
Surgery 手术 11900 – 11900 CNY Per-item price 项目价

The bars share one scale across the rows above: each starts at that row's lower published figure and ends at its upper one. The highest upper figure on this page is 11900 CNY. Each row keeps its own data year and caliber.

2 cost ranges for this condition, each with its source on the row page.

Values written in Chinese are quoted as published by the source.

See all cost ranges →

Outcomes and care quality

Live birth rate per cycle, 2017-2021: IVF 48.26-50.16% (under 35) / 28.69-31.45% (35 and over); ICSI 45.84-47.90% (under 35) / 25.98-27.11% (35 and over); FET 37.98-43.05%

CSRM registry (grade B, not a nationally weighted average): 194-293 centres reported of 635 licensed, so the rate is not national.

Source retrieved 2026-10-01.

The figure is an official publication, quoted as published - it is not our assessment or our recommendation.

Hospitals with a published record for this condition

Selected using official public data sources

These hospitals are selected from official public data sources — the Fudan University hospital specialty reputation rankings, the national key clinical specialties list and national clinical research centres — so each line on a card can be checked against its published source. This is not a paid or promoted listing.

How these hospitals were selected

Admission. A hospital is listed for a condition when the specialty that condition is filed under carries at least one of: a place or a nomination in the Fudan University hospital specialty reputation ranking; a national key clinical specialty record at level A, B or C; or a national clinical research centre or a state key laboratory in that specialty. JCI accreditation is shown as a badge; it never decides admission and it never decides order.

Order. Step 1: a Fudan place between 1 and 10 for the specialty. Step 2: another Fudan place, or a nomination. Step 3: a level-A national key clinical specialty. Step 4: a level-B national key clinical specialty. Step 5: a national clinical research centre or a state key laboratory in the specialty, a centre before a laboratory. Step 6: a level-C national key clinical specialty, which is a record we publish without an independent official source and which is therefore listed after the others.

Ties. Within one step: the better Fudan place first, then the stronger key-specialty level (A before B before C), then the province, then the city, then the hospital name - the same province-city-name order the hospital directory uses. At most eight hospitals are listed.

When the list is short. Five hospitals or more: the first eight are listed. Three or four: all of them are listed, and a further fold adds the remaining records up to eight, each carrying its evidence level. One or two: the same, with that fold open and a line stating how many hospitals have a strong public record. None: the page states that no strong public record was found and links to the specialty directory. A place, an institution or a count is never invented to fill the list.

The Fudan rankings are the hospital specialty reputation ranking most widely recognised by Chinese clinicians, published annually by Fudan University's hospital management institute.

  1. Renji Hospital, Shanghai Jiao Tong University School of Medicine上海交通大学医学院附属仁济医院

    Shanghai 上海市

    National key clinical specialty

    Also ranked: Urology #6, Gynecology #10, Gastroenterology #1 in the Fudan list.

  2. West China Second University Hospital, Sichuan University四川大学华西第二医院

    Chengdu 成都市

    National key clinical specialty

    Also ranked: Gynecology #6 in the Fudan list.

  3. First Affiliated Hospital of Zhengzhou University郑州大学第一附属医院

    Zhengzhou 郑州市

    National key clinical specialty

    Also ranked: General Surgery nominated, Thoracic Surgery nominated, Gynecology nominated in the Fudan list.

  4. Peking University First Hospital北京大学第一医院

    Beijing 北京市

    National key clinical specialty

    Also ranked: Urology #2, Infectious Diseases 传染感染 #9, General Surgery nominated in the Fudan list.

  5. Peking University Third Hospital北京大学第三医院

    Beijing 北京市

    National key clinical specialty

    Also ranked: Gynecology #4, Urology nominated, Gastroenterology nominated in the Fudan list.

Clinical trials (investigational treatments)

In addition to standard care, clinical research studies for Assisted reproduction (IVF) may currently be open to participants in China. The treatments under study have not been approved by the regulator as standard therapy — they are clinical research, not routine treatment. Each record names the lead investigator and the hospital running the study. If you are interested, contact the hospital to ask about eligibility and choose whether to apply.

  1. Study Exogenous Luteinizing Hormone Supplementation to Improve Embryo Quality in Patients With Excessive LH Suppression During a Long GnRH-Agonist Protocol: A Randomized Controlled Trial

    Lead investigator
    Li-jun Ding · Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
    Hospital
    Nanjing Drum Tower Hospital
    Status
    Recruiting
    Registry
    NCT07128394

  2. Study Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized Trial

    Lead investigator
    Chen Zi-Jiang · Academician
    Hospital
    Qilu Hospital of Shandong University
    Status
    Recruiting
    Registry
    NCT06064669

  3. Study A Multicenter, Prospective, Randomized Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on IVF-ET Outcomes in Infertile Patients With Non-recurrent Miscarriage

    Hospital
    Xiangya Hospital of Central South University
    Status
    Recruiting
    Registry
    NCT07611656

  4. Study The Feasibility of Transcutaneous Auricular Vagus Nerve Stimulation on Pregnancy Outcomes of Infertility Patients Undergoing in Vitro Fertilization: Study Protocol for a Pilot Randomized Controlled Trial

    Lead investigator
    Liu Yonghong, MD
    Status
    Recruiting
    Registry
    NCT06742788

  5. Study A Large-scale, Prospective Cohort Study Was Conducted to Explore the Association Between Environmental Exposure and Behavioral Factors and Infertility (the Success Rate of Assisted Reproductive Technology)

    Hospital
    Xiangya Hospital of Central South University
    Status
    Recruiting
    Registry
    NCT07641387
5 more registered studies

  1. Study A Phase I Clinical Trial to Compare the Pharmacokinetics, Safety and Immunogenicity of SJ04 and Ovidrel® in Healthy Female Subjects in China

    Hospital
    Suzhou Municipal Hospital
    Status
    Recruiting
    Registry
    NCT06599528

  2. Study Prospective Cohort Study for Newborns From Patients Treated With ART in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)

    Lead investigator
    Zhiqin Bu · Doctor of Reproductive Medical Center
    Hospital
    First Affiliated Hospital of Zhengzhou University
    Status
    Recruiting
    Registry
    NCT03993158

  3. Study Effectiveness Of Bushen Tongzhi Formula Pretreatment On Pregnancy Outcomes In Infertile Women With Diminished Ovarian Reserve Undergoing In Vitro Fertilization And Embryo Transfer: Study Protocol For A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (PRIME Study)

    Hospital
    Peking Union Medical College Hospital
    Status
    Not yet recruiting
    Registry
    NCT07347340

  4. Study A Multi-center, Single-arm, Observational Study to Assess the Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)

    Hospital
    Peking University Third Hospital
    Status
    Not yet recruiting
    Registry
    NCT07553728

  5. Study Effect of Salidroside on Pregnancy Outcomes in High Childbearing Age Patients in Viro Fertilization: an Open-label Randomized Controlled Trial

    Lead investigator
    Linlin Cui · Professor
    Hospital
    The Second Hospital of Shandong University
    Status
    Not yet recruiting
    Registry
    NCT06990685

This page only shares publicly registered study information. It does not recommend or encourage joining any study. Participation is entirely voluntary and the risks of an unapproved treatment are unknown; contact the hospital directly for eligibility and informed-consent details.

Hospitals with a national key specialty record

Show the hospital records 5 hospitals with a key-specialty record

Each row is a hospital with a national key clinical specialty record in a specialty this condition is filed under. This is a record of published listings, not a recommendation and not a ranking.

Hospital City Specialty (as published) Evidence Source
Renji Hospital, Shanghai Jiao Tong University School of Medicine上海交通大学医学院附属仁济医院 Shanghai 上海市 Reproductive Medicine 女性生殖障碍疾病全生育周期创新诊疗体系的建设与质量提升（项目名） Level A https://wsjkw.sh.gov.cn/ggl1/20260610/cb3c873f00c14e8fa2b1e7357e3a45b8.html
Peking University First Hospital北京大学第一医院 Beijing 北京市 Reproductive Medicine 生殖医学科 Level B https://www.pkufh.com/Html/News/Articles/64494.html
Peking University Third Hospital北京大学第三医院 Beijing 北京市 Reproductive Medicine 生殖医学科 Level B https://www.puh3.net.cn/yygk/zdxk.htm
West China Second University Hospital, Sichuan University四川大学华西第二医院 Chengdu 成都市 Reproductive Medicine 生殖医学科牵头（不孕不育综合诊疗平台建设项目） Level A https://wcums.scu.edu.cn/kxyan_jiu/gjlczdzk.htm
First Affiliated Hospital of Zhengzhou University郑州大学第一附属医院 Zhengzhou 郑州市 Reproductive Medicine 生殖医学科 Level A https://m.henan.gov.cn/2023/09-08/2811482.html

5 hospitals with a matching national key specialty record.

Values written in Chinese are quoted as published by the source.

Questions about this condition

We cannot give medical advice, but we can answer questions about this page and about arranging treatment in China.

Ask us about this condition

ICD codes

Show the code table 2 ICD codes
Version Code Name in that version
ICD-10-WHO Z31 Procreative management
ICD-10-WHO Z31.2 In vitro fertilisation

Rows are the WHO ICD-10 entries for this condition, quoted as published.

Source & evidence

Source URL
https://www.nhsa.gov.cn/art/2024/5/31/art_14_12835.html
Source scheme
https
Source type
National Health Commission
Evidence level
A - said by a provincial health commission or university
Retrieved on
2026-09-30